Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purine-nucleoside phosphorylase (PNP) is an enzyme that catalyzes the reversible phosphorolysis of purine nucleosides into their corresponding purine bases and ribose 1-phosphate or deoxyribose 1-phosphate. It plays a crucial role in purine salvage and is essential for nucleotide homeostasis. Deficiency in PNP leads to immunodeficiency and other disorders, making it a drug target for modulating immune responses in cancer chemotherapy and autoimmune diseases.
Inhibition of PNP activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine-nucleoside phosphorylase (PNP).